MicroRNA in disease regulation

MicroRNAs are short, non-coding RNA molecules that fine-tune gene expression by binding to messenger RNAs and suppressing their translation, giving cells a precise layer of control over which proteins get made and in what amounts. In cancer, this system frequently goes wrong — specific microRNAs are overproduced or silenced in tumor cells, tipping the balance toward uncontrolled growth, invasion, or resistance to treatment, which has made them attractive both as diagnostic biomarkers detectable in blood and tissue and as potential therapeutic targets. Researchers are actively working to understand how microRNAs are produced and processed inside the cell, how they select their gene targets with enough specificity to be clinically useful, and how therapeutic molecules can be designed to restore or block their activity without triggering unintended effects elsewhere in the genome.

Works

145,786

Total citations

3,827,055

Keywords

MicroRNAGene ExpressionCancerRegulationBiomarkersBiogenesis